The main reason analgin is banned in over 30 countries is the risk of — a potentially fatal condition where granulocyte levels drop below 500/μL, leading to severe infections. Incidence rates are debated: older studies suggest 1 in 1,000 to 1 in 5,000 users; newer meta-analyses place it closer to 1 in 1.4 million prescriptions in short-term use. Nonetheless, regulatory agencies like the FDA have not approved it since 1977.
The most plausible interpretation is that “Aanalginn” is a misspelled or deliberately obfuscated form of — a well-known but controversial painkiller. Analgin’s generic name is metamizole or dipyrone . It is a non-opioid analgesic and antipyretic, widely used in many countries (e.g., Brazil, Russia, India, Germany under restricted conditions) but banned or restricted in others (e.g., USA, UK, Japan, Australia) due to the risk of agranulocytosis — a severe drop in white blood cells. Aanalginn 08062022 015015-51 Min BETTER
It sounds like a spell from Harry Potter, but it’s actually a perfect example of how machines communicate with us. Let's break it down. The main reason analgin is banned in over